Vericel Corporation logo
Vericel Corporation VCEL
$ 36.92 3.59%

Annual report 2025
added 02-26-2026

report update icon

Vericel Corporation Cash Conversion Cycle 2011-2026 | VCEL

Annual Cash Conversion Cycle Vericel Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
84.2 48 66.9 105 109 112 104 53.9 83.2 75.4 -7.73 21.4 -215 K -172 K -204 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
112 -215 K -39.4 K

Quarterly Cash Conversion Cycle Vericel Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
102 96.4 82 - 32.6 38.8 53 - 69.1 86.8 105 - 70.1 60.6 127 - 125 93.1 100 69.6 122 185 128 74.5 101 117 100 68.3 95.2 113 106 71.4 117 98.3 172 94.4 143 122 90.6 64.6 88.1 73.3 80.4 50.8 77.4 169 - - - 122 160 88.8 411 456 456 - 91.2 91.2 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
456 32.6 118

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-2.85 K - -11.43 % $ 502 K usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
205 $ 21.65 1.12 % $ 1.01 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-400 $ 0.9 -0.18 % $ 6.62 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
257 $ 22.3 1.55 % $ 3.7 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
340 - -4.8 % $ 255 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
11.9 - - $ 35.4 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
ChromaDex Corporation ChromaDex Corporation
CDXC
-51.6 - -0.88 % $ 598 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
-172 $ 4.1 0.49 % $ 438 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
158 $ 23.42 0.69 % $ 2.98 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
119 $ 1.42 -1.39 % $ 378 M britainBritain
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
-54.4 - - $ 546 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
-1.83 K - -5.16 % $ 5.39 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.72 - $ 115 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
-216 - - $ 1.2 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
-32.5 K $ 1.09 2.83 % $ 13.3 M usaUSA